Mitigation of Metabolic Diseases Through Personalized Nutrition: A Critical In‐Depth Review.
Saved in:
| Title: | Mitigation of Metabolic Diseases Through Personalized Nutrition: A Critical In‐Depth Review. |
|---|---|
| Authors: | Arshad, Muhammad Tayyab1 (AUTHOR), Ali, M. K. M.2 (AUTHOR), Awlqadr, Farhang Hameed3 (AUTHOR), Maqsood, Sammra4 (AUTHOR), Ikram, Ali5 (AUTHOR), Hossain, Md. Sakhawot6 (AUTHOR), Abdullahi, Muhammed Adem7 (AUTHOR) muhammed.adem@ju.edu.et, Rashed, M. M.2 (AUTHOR) |
| Source: | Food Science & Nutrition. Jan2026, Vol. 14 Issue 1, p1-20. 20p. |
| Subject Terms: | Type 2 diabetes, Obesity, Gut microbiota, Cardiovascular diseases, Nutritional genomics, Metabolic disorders, Individualized medicine, Nutrition |
| Abstract: | Obesity, cardiovascular disease, and type 2 diabetes mellitus (T2DM) represent major global health and economic concerns. Traditional dietary recommendations frequently overlook individual heterogeneity in metabolic health. Personalized nutrition will provide a more focused approach to preventing chronic diseases by tailoring dietary recommendations according to lifestyle, metabolic, and genetic factors. This review examines the role of personalized nutrition in preventing metabolic diseases, with a focus on key components of nutrient‐gene interactions, including nutrigenomics, nutrigenetics, the gut microbiome, and biomarker‐based therapies. The main aim of this article is to investigate how variation within the microbiome and among genes impacts nutrient metabolism and make a case for successful evidence of individualized dietary intervention for obesity, diabetes, and cardiovascular disease. Future advancements in artificial intelligence, and genetic testing may make personalized nutrition more accessible, but there are questions about the price, feasibility, and ethics of its widespread use. The scope for personalized nutrition is wide and has strong potential to impact preventative health. An independent assessment calls for sustained scientific research, equitable accessibility, and ethical considerations that can make public health policies clinically relevant. [ABSTRACT FROM AUTHOR] |
| Copyright of Food Science & Nutrition is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | GreenFILE |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Obesity, cardiovascular disease, and type 2 diabetes mellitus (T2DM) represent major global health and economic concerns. Traditional dietary recommendations frequently overlook individual heterogeneity in metabolic health. Personalized nutrition will provide a more focused approach to preventing chronic diseases by tailoring dietary recommendations according to lifestyle, metabolic, and genetic factors. This review examines the role of personalized nutrition in preventing metabolic diseases, with a focus on key components of nutrient‐gene interactions, including nutrigenomics, nutrigenetics, the gut microbiome, and biomarker‐based therapies. The main aim of this article is to investigate how variation within the microbiome and among genes impacts nutrient metabolism and make a case for successful evidence of individualized dietary intervention for obesity, diabetes, and cardiovascular disease. Future advancements in artificial intelligence, and genetic testing may make personalized nutrition more accessible, but there are questions about the price, feasibility, and ethics of its widespread use. The scope for personalized nutrition is wide and has strong potential to impact preventative health. An independent assessment calls for sustained scientific research, equitable accessibility, and ethical considerations that can make public health policies clinically relevant. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 20487177 |
| DOI: | 10.1002/fsn3.71387 |
